fashion -WSS

fashion

author：entertainment 2025-09-29 21:25:27 - browse：3

Adam's take main illustration — Molly Ferguson/STAT

Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial results might be forced, finally, to tell the truth when it reads out its next study in Rett syndrome.

What sets Anavex apart from all the other biotechs on my radar screen is its habit of shifting the goalposts on clinical trials. Twice last year, first in February and then in December, Anavex announced “positive” outcomes from studies of its drug called blarcamesine — except the results were derived from efficacy endpoints that were not part of the original study designs.

If blarcamesine fails to achieve the pre-determined goals of clinical trials, the thinking apparently goes, then just make a post-hoc change to the study goals.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Anesthesiologist group: stop taking Ozempic before surgery

hotspot

WSS

At least 13 dead in Texas as scorching temps continue

The high cost of giving birth even with insurance

The cancer drug shortage isn’t new — and neither are the solutions

After affirmative action ruling, medical educators look to 'holistic review'

State Dept. review finds Biden bears some blame for Afghanistan failures

What AAP's gender

Wikipedia

fashion

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Medical leaders decry Supreme Court decision on affirmative action

Sports medicine is finally prioritizing gender equality

FDA panel gives mixed vote on blood pressure devices

Dobbs anniversary: the lost opportunity of abortion as health care

What does generative AI mean for health care? We asked experts

What does generative AI mean for health care? We asked experts

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Radiation, mainstay of cancer treatment, begins a fade

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Australia’s approach to dialysis celebrates life

Why more medical students aren't specializing in primary care

Complete sequence of Y chromosome published for first time

In age of alternative facts, a scholarly course on calling out crap

Trump demands the U.S. pay no more for drugs than other countries … again

explore

knowledge

hotspot

focus